Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Shilpa Medicare bags CDSCO nod for topical hemostatic spray of Tranexamic Acid

Ruchika Sharma22 Sept 2022 2:59 PM IST

The product is protected by granted patents in India till 2037 and in US, Australia, Russia and South Africa till 2038.

AstraZeneca Severe Asthma treatment Tezspire gets nod in EU

Ruchika Sharma22 Sept 2022 2:00 PM IST

Tezspire (tezepelumab) is being developed by AstraZeneca in collaboration with Amgen.

Should UCPMP be made legally binding on Pharma Companies? Govt sets up high level committee to review

Ruchika Sharma22 Sept 2022 12:59 PM IST

New Delhi: Should the Uniform Code of Pharmaceutical Marketing Practices be made mandatory for Pharma companies? The decision to this issue may soon...

Hearing loss therapy: Fennec Pharma gets USFDA nod for PEDMARK

Ruchika Sharma22 Sept 2022 12:00 PM IST

"The FDA approval of PEDMARK represents an important breakthrough for pediatric patients with localized, non-metastatic solid tumors at risk for...

Himachal Pradesh Chief Minister says Bulk Drug Pharma Park will ensure pharma units stay in the state

Ruchika Sharma22 Sept 2022 11:00 AM IST

As per the regulations, the Department of Pharmaceuticals (DoP), Government of India, was required to contribute 90 per cent of the project's costs,...

No Generics for AbbVies Rinvoq Until 2037, Analysts See Multi-Billion Dollar Boost

AbbVie receives EMA Committee positive opinion for Crohn's Disease treatment Risankizumab

Ruchika Sharma21 Sept 2022 3:30 PM IST

SKYRIZI is an interleukin-23 (IL-23) inhibitor that selectively blocks IL-23 by binding to its p19 subunit.

Shortage of antiretroviral drugs for treating HIV patients: SC issues notice to Centre

Ruchika Sharma21 Sept 2022 2:15 PM IST

The plea contended that non-availability of drugs at the Anti Retro Viral Therapy Centres of the National AIDS Control Organisation results in...

USFDA Issues Warning Letter to Cohance Lifesciences Hyderabad FDF Unit

USFDA warning: Medtronic MiniMed 600 Series insulin pump system vulnerable to cyberattacks

Ruchika Sharma21 Sept 2022 1:15 PM IST

The company said hackers, however, cannot gain access to the device through the internet.

Zydus Lifesciences US arm, BridgeBio Pharma get European Commission nod for NULIBRY to treat MoCD Type A

Ruchika Sharma21 Sept 2022 12:15 PM IST

Ahmedabad: Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company owned by Zydus Lifesciences Ltd and BridgeBio Pharma, Inc., a...

Indian shares rise 1 percent lifted by pharma

Ruchika Sharma21 Sept 2022 11:18 AM IST

Foreign investors on Monday sold $435.6 million worth of Indian equities, Refinitiv Eikon data showed.

Zydus Lifesciences launches cancer drug Lenalidomide in US

Ruchika Sharma20 Sept 2022 4:00 PM IST

Ahmedabad: Drugmaker, Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited), has recently announced that the company has...

Haleon believes it is not liable for any potential Zantac liabilities

Ruchika Sharma20 Sept 2022 3:30 PM IST

Haleon has repeatedly said that it never marketed Zantac in any form in the United States, either as Haleon or as GSK Consumer Healthcare.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok